Changes and Clinical Significance of PIVKA-II in Hepatitis E Patients

Increased protein induced by vitamin K absence or antagonist-II (PIVKA-II) levels had been widely reported in patients with hepatocellular carcinoma (HCC) and chronic hepatitis. However, the role of PIVKA-II in hepatitis E is unclear. The aim of this study was to clarify the changes related with PIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Youran, Yang, Yanyan, Li, Shanshan, Lin, Minghao, Xie, Xueting, Shi, Huifang, Jiang, Yuchun, Zheng, Sijie, Shao, Hui, Yang, Naibin, Lu, Mingqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821524/
https://www.ncbi.nlm.nih.gov/pubmed/35145947
http://dx.doi.org/10.3389/fpubh.2021.784718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821524/
https://www.ncbi.nlm.nih.gov/pubmed/35145947
http://dx.doi.org/10.3389/fpubh.2021.784718

Ejemplares similares